Found: 81
Select item for more details and to access through your institution.
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
- By:
- Publication type:
- Article
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11431-1
- By:
- Publication type:
- Article
Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients.
- Published in:
- Liver International, 2012, v. 32, n. 5, p. 826, doi. 10.1111/j.1478-3231.2011.02727.x
- By:
- Publication type:
- Article
Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2015, v. 87, n. 11, p. 1904, doi. 10.1002/jmv.24244
- By:
- Publication type:
- Article
α-Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir-based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with the IL 28 B minor genotype.
- Published in:
- Journal of Medical Virology, 2014, v. 86, n. 3, p. 461, doi. 10.1002/jmv.23824
- By:
- Publication type:
- Article
New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 9, p. 1523, doi. 10.1002/jmv.23626
- By:
- Publication type:
- Article
Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 7, p. 1180, doi. 10.1002/jmv.23597
- By:
- Publication type:
- Article
Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 1, p. 65, doi. 10.1002/jmv.23428
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
- By:
- Publication type:
- Article
Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 125, doi. 10.1111/hepr.13256
- By:
- Publication type:
- Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
- Published in:
- Hepatology Research, 2018, v. 48, n. 7, p. 549, doi. 10.1111/hepr.13058
- By:
- Publication type:
- Article
Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
- Published in:
- Hepatology Research, 2017, v. 47, n. 11, p. 1165, doi. 10.1111/hepr.12879
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
- Published in:
- Hepatology Research, 2017, v. 47, n. 13, p. 1429, doi. 10.1111/hepr.12910
- By:
- Publication type:
- Article
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1308, doi. 10.1111/hepr.12898
- By:
- Publication type:
- Article
Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.
- Published in:
- Hepatology Research, 2017, v. 47, n. 7, p. 641, doi. 10.1111/hepr.12784
- By:
- Publication type:
- Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
- Published in:
- Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
- By:
- Publication type:
- Article
Effect of native vitamin D<sub>3</sub> supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
- Published in:
- Hepatology Research, 2016, v. 46, n. 5, p. 450, doi. 10.1111/hepr.12575
- By:
- Publication type:
- Article
Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype.
- Published in:
- Hepatology Research, 2015, v. 45, n. 4, p. 387, doi. 10.1111/hepr.12360
- By:
- Publication type:
- Article
A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E386, doi. 10.1111/hepr.12323
- By:
- Publication type:
- Article
Serum 25-hydroxyvitamin D<sub>3</sub> levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1277, doi. 10.1111/hepr.12298
- By:
- Publication type:
- Article
Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2013, v. 43, n. 5, p. 459, doi. 10.1111/j.1872-034X.2012.01097.x
- By:
- Publication type:
- Article
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
- Published in:
- BMC Infectious Diseases, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2334-12-324
- By:
- Publication type:
- Article
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
- By:
- Publication type:
- Article
Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1677, doi. 10.1111/liv.15624
- By:
- Publication type:
- Article
A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2944, doi. 10.1111/liv.15022
- By:
- Publication type:
- Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
- By:
- Publication type:
- Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
- By:
- Publication type:
- Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
- By:
- Publication type:
- Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
- By:
- Publication type:
- Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
- By:
- Publication type:
- Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
- By:
- Publication type:
- Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
- By:
- Publication type:
- Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
- By:
- Publication type:
- Article
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
- By:
- Publication type:
- Article
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336
- By:
- Publication type:
- Article
Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naive Genotype 1b Chronic Hepatitis C Patients.
- Published in:
- Gastroenterology Research & Practice, 2014, p. 1, doi. 10.1155/2014/549709
- By:
- Publication type:
- Article
Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96089-x
- By:
- Publication type:
- Article
Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93794-5
- By:
- Publication type:
- Article
A novel glycobiomarker, W isteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 6, p. 1462, doi. 10.1002/ijc.29880
- By:
- Publication type:
- Article
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170667
- By:
- Publication type:
- Article
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164418
- By:
- Publication type:
- Article
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 12, p. 1, doi. 10.5812/hepatmon.14872
- By:
- Publication type:
- Article